Condition: Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Esophageal Squamous Cell Carcinoma · Sponsor: Hummingbird Bioscience
This is a Phase Ib/II multi-center, open-label study of HMBD-001 in combination with cetuximab with or without docetaxel in participants with advanced Squamous Cell Cancers
This description comes directly from the study's public registry record.
Kevin Heller, Dr · +65 6978 9377 · k.heller@hummingbirdbio.com
Always discuss trial participation with your own doctor first.
| GenesisCare North Shore | Sydney, New South Wales, Australia | Withdrawn |
| Westmead Hospital | Westmead, New South Wales, Australia | Recruiting |
| ICON Cancer Centre South Brisbane | Brisbane, Queensland, Australia | Withdrawn |
| Greenslopes Private Hospital | Greenslopes, Queensland, Australia | Recruiting |
| Southern Oncology Clinical Research Unit | Adelaide, South Australia, Australia | Recruiting |
| Peninsula & South Eastern Haematology and Oncology Group | Frankston, Victoria, Australia | Recruiting |
| Cabrini Health | Malvern, Victoria, Australia | Withdrawn |
| Linear Clinical Research | Perth, Western Australia, Australia | Recruiting |
| The Institute of Oncology, ARENSIA Exploratory Medicine Phase I Unit | Chisinau, Moldova | Recruiting |
| National Cancer Centre Singapore | Singapore, Singapore | Recruiting |
| Tan Tock Seng Hospital | Singapore, Singapore | Recruiting |
| Chungbuk National University Hospital | Cheongju-si, South Korea | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05910827